In harmony with this prediction, the list of typically early drivers includes most of the CpG-dependent cancer driver genes identified in the present work, such as TP53, PIK3CA, CDKN2A, PTEN, APC, RB1, FBXW7, NFE2L2, IDH1, PIK3R128. The gene discussed is NFE2L2; the disease is cancer.